#

Prof. Matthew Kiernan

Chief Executive Officer and Institute Director, Neuroscience Research Australia Scientia Professor of Neuroscience at the University of New South Wales, Sydney, Australia Senior Staff Specialist in Neurology, South Eastern Sydney Local Health District

Dementia care is facing immense challenges worldwide, with the growing number of diagnoses and lack of effective therapies. In this video, Professor Matthew Kiernan discusses the complexities of dementia research, including recent insights into neurobiological aetiologies, and promising developments for therapeutics. From targeted monoclonal antibody treatments for specific proteins linked to various forms of dementia, to the critical role of lifestyle and preventative care, Professor Kiernan outlines a multifaceted approach to tackling this global issue.

Related content

The Challenges and Potential of Clinical Trials in Dementia Research play_circle Video play_circle
The Challenges and Potential of Clinical Trials in Dementia Research

Professor Dr. Matthew Kiernan discusses the limitations of current trial models.

12.11.2024 Alzheimer’s Disease
image Image Stroke, migraine, AD and other dementias were among the top ten conditions that accounted for the greatest nervous system DALYs in 2021
Highlights from the Global Burden of Disease 2021 Study

Stroke, migraine, Alzheimer’s Disease and other dementias were among the top ten conditions that accounted for the greatest nervous system DALYs in 2021

25.07.2024 Alzheimer’s Disease
description Article
Global perspectives on Alzheimer’s disease diagnosis and treatment: challenges and considerations in resource-limited settings

Alzheimer’s disease (AD) is the most prevalent neurodegenerative disease and the leading cause of dementia worldwide, regardless of socioeconomic status.

09.07.2024 Alzheimer’s Disease